CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 391.00
-10.00 (-2.49%)
Apr 17, 2026, 3:30 PM JST
CellSource Market Cap
CellSource has a market cap or net worth of 7.76 billion as of April 17, 2026. Its market cap has decreased by -50.23% in one year.
Market Cap
7.76B
Enterprise Value
3.14B
Revenue
3.72B
Ranking
n/a
PE Ratio
86.98
Stock Price
391.00
Market Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 7.76B, a decrease of -42.42%. That is a compound annual growth rate of -8.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 7.76B | -1.89% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| K Pharma,Inc. | 8.81B |
| BrightPath Biotherapeutics | 8.78B |
| StemCell Institute | 8.03B |
| Carna Biosciences | 8.00B |
| MEDINET | 7.99B |
| ADR120S | 7.37B |
| Chiome Bioscience | 7.30B |
| PRISM BioLab Co.,LTD | 7.17B |